Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
2.130
-0.220 (-9.36%)
At close: Nov 5, 2026, 4:00 PM EST
2.170
+0.040 (1.88%)
After-hours: Nov 5, 2026, 7:30 PM EST
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $125.87 million as of November 5, 2026. It is the 23,340th most valuable company in the world and the 3,885th biggest in the United States. Its market cap has decreased by 29.76% in one year.
Market Cap
125.87M
Enterprise Value
-33.23M
1-Year Change
-29.76%
Global Rank
Country Rank
#3,885 United States
Category
ChartMarket Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has decreased from $173.16M to $125.87M, a decrease of -27.31%. That is a compound annual growth rate of -4.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 125.87M | -55.93% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 147.62M |
| MacroGenics | 147.15M |
| NervGen Pharma | 144.08M |
| Innate Pharma | 141.28M |
| Cue Biopharma | 140.20M |
| Compass Therapeutics | 138.31M |
| Yarrow Bioscience | 137.33M |
| Satellos Bioscience | 136.86M |